Novartis to invest $250M for new therapies to fight neglected tropical diseases, malaria

Robert Way/iStock Editorial via Getty Images Novartis (NYSE:NVS) said it is committing $250M over five years to advance research and development (R&D) of new treatments to fight against neglected tropical diseases and malaria. The Swiss pharma giant made the June 23 announcement in conjunction with the Kigali Summit on Malaria and NTDs alongside the 26th … Read more